From Research findings to Therapeutic opportunity:
The study presented here suggests that Olive Leaf Extract, by increasing the expression of its target genes, it may: (i) decrease the expression of Dihydropyrimidine dehydrogenase (DPYD); (ii) increase 5-FU accumulation in cancer cells; (iii) augment and restore chemosensitivity in drug-resistant Human cancers; (iv) promote anti-tumor effect; and (v) enhance the efficacy of anticancer drug treatment.
[easy_payment currency=”USD”]
Thereby, it may inhibit proliferation, chemoresistance and apoptosis of cancer cells. Thus, pharmacological formulations encompassing “Olive Leaf Extract or an active compound isolated from it” may be used to inhibit cancer progression (Figs. 1-3).
Details of the research findings:
Idea Proposed/Formulated (with experimental evidence) by:
Dr L Boominathan Ph.D.
Undisclosed information: How Olive Leaf Extract decreases the expression of Dihydropyrimidine dehydrogenase (DPYD)?
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Amount: $5
For purchase and payment details, you may reach us at info@genomediscovery.org
References:
Citation: Boominathan, L., Natural product-derived combination therapy for augmenting the anti-cancer drug 5-FU (5-Flurouracil) sensitivity in Human cancers: Olive Leaf Extract decreases the expression of the rate-limiting enzyme of the ‘uracil catabolic pathway’ Dihydropyrimidine dehydrogenase (DPYD), increases 5-FU accumulation in cancer cells, augments chemosensitivity, and anti-tumor effect via upregulation of its target gene, 6/January/2017, 11.40 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org or newbioideas.com/
Courtesy: When you cite drop us a line at info@genomediscovery.org